1. HBW Insight
  2. >>Geography
  3. >>Europe

People On The Move: Appointments At Viatris, HFMA, Biofarma

 
• By Tom Gallen

A round up of the latest appointments in the health and wellness sector: Viatris names Scott Smith CEO as it prepares to exit OTC; the UK's Health Food Manufacturers' Association plans leadership change; Italy's Biofarma hires ex-Almirall CEO to lead company.

Hired
• Source: Alamy

Viatris Inc has named Scott Smith as its new CEO, effective from 1 April 2023. He will replace as CEO Michael Gottler, who has led the company since November 2020.

Formerly president of BioAtla Inc, and a member of the Viatris board since December 2022, Smith has been appointed to lead the Pittsburgh, PA-based firm as it executes a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Melatonin And Buccal Acyclovir On German Switch Committee Agenda

 
• By David Ridley

An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By David Ridley

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By David Ridley

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.